Unnati Pharmax

CAL D3 Injection
Composition: Vitamin D3 (Cholecalciferol) Injection

CAL D3 is a high-quality Vitamin D3 Injection, a clinically recognized preparation for the prevention and treatment of Vitamin D deficiency. Manufactured in WHO-GMP certified facilities, CAL D3 Injection is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in the management of bone and mineral metabolism disorders.

Vitamin D3 plays a crucial role in calcium and phosphate homeostasis, promoting proper bone mineralization and supporting immune and muscle function. CAL D3 Injection is primarily indicated for the prevention and treatment of rickets, osteomalacia, osteoporosis, hypocalcemia, and other conditions associated with Vitamin D deficiency, under medical supervision.

CAL D3 Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, clinics, government health programs, and international pharmaceutical distributors.

VEGA-EXTRA Oral Jelly
Composition: Sildenafil Citrate 120mg
International Trade Name: Viagra®

VEGA-EXTRA is a high-quality Sildenafil Citrate 120mg Oral Jelly, a fast-acting phosphodiesterase type 5 (PDE5) inhibitor widely recognized for its effectiveness in the management of erectile dysfunction. Manufactured in WHO-GMP certified facilities, VEGA-EXTRA is supplied by trusted pharmaceutical exporters from India to support global men’s health programs with convenient and patient-friendly dosage forms.

Sildenafil Citrate works by enhancing blood flow to the penile region during sexual stimulation, helping men achieve and maintain a firm erection. The oral jelly formulation allows for quicker absorption and ease of administration, making VEGA-EXTRA especially suitable for patients who have difficulty swallowing tablets. It is primarily indicated for the treatment of erectile dysfunction in adult men under medical supervision.

VEGA-EXTRA Sildenafil Oral Jelly 120mg is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The product is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for pharmacies, clinics, hospitals, and international pharmaceutical distributors.

TESTO-E Injection
Composition: Testosterone Enanthate
Dosage Form: Injectable

TESTO-E is a high-quality Testosterone Enanthate injection, a long-acting androgen widely recognized for its effectiveness in testosterone replacement therapy (TRT) and the management of conditions associated with low testosterone levels in adult males. Manufactured in WHO-GMP certified facilities, TESTO-E Injection is supplied by trusted pharmaceutical exporters from India to support global hormone therapy and men’s health programs.

Testosterone Enanthate works by restoring and maintaining normal testosterone levels in the body, supporting the development and maintenance of male secondary sexual characteristics, muscle mass, bone density, libido, and overall vitality. TESTO-E Injection is primarily indicated for the treatment of male hypogonadism and other conditions resulting from insufficient endogenous testosterone production, as prescribed by a healthcare professional.

TESTO-E Testosterone Enanthate Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, specialty clinics, government health programs, and international pharmaceutical distributors.

Mofilet 500 Tablets
Composition: Mycophenolate Mofetil IP 500mg
Dosage Form: Oral Tablet

Mofilet 500 is a high-quality Mycophenolate Mofetil 500mg tablet, a potent immunosuppressant widely recognized for its efficacy in preventing organ transplant rejection. Manufactured in WHO-GMP certified facilities, Mofilet is supplied by trusted pharmaceutical exporters from India to support advanced global transplant care programs.

Mycophenolate Mofetil works by inhibiting the proliferation of T- and B-lymphocytes, thereby reducing the risk of graft rejection following kidney, heart, or liver transplantation. Mofilet 500mg Tablets are primarily indicated for the prevention of organ transplant rejection in combination with other immunosuppressive agents, and in the treatment of certain autoimmune disorders as prescribed by a physician.

Mofilet 500 Mycophenolate Mofetil Tablets are manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

LETROHEAL 2.5mg Tablets
Composition: Letrozole 2.5mg Tablets
International Trade Name: Femara®

LETROHEAL 2.5mg is a high-quality Letrozole 2.5mg Tablet, a well-established aromatase inhibitor marketed under the brand name Femara®. Manufactured in WHO-GMP certified facilities, LETROHEAL Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hormone receptor-positive breast cancer.

Letrozole works by selectively inhibiting the aromatase enzyme, thereby reducing estrogen production and limiting the growth of estrogen-dependent breast cancer cells. LETROHEAL 2.5mg Tablets are primarily indicated for the treatment of postmenopausal women with hormone receptor-positive early or advanced breast cancer and for adjuvant therapy following surgery or chemotherapy.

 

LETROHEAL 2.5mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, oncology centers, government cancer programs, and international pharmaceutical distributors.

P-Force Oral Jelly
Composition: Sildenafil Citrate 100mg & Dapoxetine 60mg
Dosage Form: Oral Jelly

P-Force Oral Jelly is a high-quality combination formulation containing Sildenafil 100mg and Dapoxetine 60mg, designed to address both erectile dysfunction (ED) and premature ejaculation (PE) in adult men. Manufactured in WHO-GMP certified facilities, P-Force Oral Jelly is supplied by trusted pharmaceutical exporters from India to support global men’s health and wellness programs.

Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penile region, helping achieve and maintain a firm erection during sexual activity. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that helps delay ejaculation and improve control. Together, this dual-action formulation provides comprehensive support for improved sexual performance and satisfaction. P-Force Oral Jelly is primarily indicated for men experiencing both erectile dysfunction and premature ejaculation.

P-Force Oral Jelly is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The jelly is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for pharmacies, men’s health clinics, wellness centers, and international pharmaceutical distributors.

TOPOTYRA 2.5mg/2.5ml Injection
Composition: Topotecan Injection IP 2.5mg/2.5ml
Dosage Form: Injectable

TOPOTYRA is a high-quality Topotecan Injection IP, a well-established topoisomerase I inhibitor widely recognized for its efficacy in the treatment of various solid tumors. Manufactured in WHO-GMP certified facilities, TOPOTYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Topotecan works by inhibiting the enzyme topoisomerase I, which is essential for DNA replication in cancer cells. This action leads to DNA damage and ultimately results in the death of rapidly dividing tumor cells. TOPOTYRA 2.5mg/2.5ml Injection is primarily indicated for the treatment of ovarian cancer, small cell lung cancer, and cervical cancer, either as monotherapy or in combination regimens, as per established clinical protocols.

TOPOTYRA Topotecan Injection IP is manufactured under stringent GMP and oncology-grade quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Myfocept-S 180 Tablets
Composition: Mycophenolate Sodium 180mg
Dosage Form: Oral Tablet

Myfocept-S 180 is a high-quality Mycophenolate Sodium 180mg tablet, a potent immunosuppressant widely recognized for its efficacy in preventing organ transplant rejection and managing certain autoimmune disorders. Manufactured in WHO-GMP certified facilities, Myfocept-S 180 is supplied by trusted pharmaceutical exporters from India to support advanced global transplant care and immunology programs.

Mycophenolate Sodium works by selectively inhibiting the proliferation of T- and B-lymphocytes, thereby reducing the risk of graft rejection following kidney, heart, or liver transplantation. Myfocept-S 180 Tablets are primarily indicated for the prevention of organ transplant rejection in combination with other immunosuppressive agents and for the treatment of autoimmune conditions as prescribed by a healthcare professional.

Myfocept-S 180 Mycophenolate Sodium Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

Rapacan 1mg Tablets
Composition: Sirolimus 1mg Tablets
International Trade Name: Rapamune®

Rapacan 1mg is a high-quality Sirolimus 1mg Tablet, a well-established immunosuppressive agent marketed under the brand name Rapamune®. Manufactured in WHO-GMP certified facilities, Rapacan Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global healthcare programs, particularly in the prevention of organ transplant rejection.

Sirolimus works by inhibiting the mammalian target of rapamycin (mTOR), thereby suppressing T-cell activation and proliferation. Rapacan 1mg Tablets are primarily indicated for the prophylaxis of organ rejection in patients receiving kidney transplants and may also be used in certain other immunomodulatory conditions under specialist supervision.

Rapacan 1mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

L-Carnibol Injection
Composition: L-Carnitine Injection

L-Carnibol is a high-quality L-Carnitine Injection, a clinically recognized supplement widely used to support energy metabolism and improve fatty acid utilization in the body. Manufactured in WHO-GMP certified facilities, L-Carnibol Injection is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in patients with carnitine deficiency, metabolic disorders, or increased energy requirements.

L-Carnitine plays a crucial role in the transport of long-chain fatty acids into the mitochondria for energy production, supporting cardiovascular health, muscle function, and overall metabolic efficiency. L-Carnibol Injection is primarily indicated for the treatment of primary and secondary carnitine deficiency, nutritional supplementation, and as an adjunct in conditions such as chronic fatigue, renal dialysis, and certain metabolic disorders.

L-Carnibol Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The ampoules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, specialty care centers, and international pharmaceutical distributors.

KAMAGRA 100 Chewable Tablets
Composition: Sildenafil Citrate 100mg
Dosage Form: Oral Chewable Tablet

KAMAGRA 100 is a high-quality Sildenafil Citrate chewable tablet, a widely recognized phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in adult men. Manufactured in WHO-GMP certified facilities, KAMAGRA 100 Chewable Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global men’s health programs.

Sildenafil Citrate works by enhancing blood flow to the penile region during sexual stimulation, helping achieve and maintain a firm erection. KAMAGRA 100 Chewable Tablets are primarily indicated for the treatment of erectile dysfunction in adult men and are designed for convenient, easy-to-take oral administration.

KAMAGRA Sildenafil Citrate Chewable Tablets 100mg are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pharmacies, men’s health clinics, government healthcare programs, and international pharmaceutical distributors.

Renocel 4000 IU Injection
Composition: Erythropoietin Injection 4000 IU
International Trade Name: Epogen® / Eprex®

Renocel 4000 IU is a high-quality Erythropoietin 4000 IU Injection, a recombinant human erythropoietin widely recognized for its role in stimulating red blood cell production. Manufactured in WHO-GMP certified facilities, Renocel Injection is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in the management of anemia associated with chronic kidney disease, chemotherapy, or other medical conditions.

Erythropoietin works by stimulating erythroid progenitor cells in the bone marrow, leading to increased production of red blood cells and improved oxygen-carrying capacity. Renocel 4000 IU Injection is primarily indicated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia induced by chemotherapy, and for other clinical situations requiring erythropoiesis-stimulating therapy under medical supervision.

Renocel 4000 IU Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, dialysis centers, tertiary care facilities, and international pharmaceutical distributors.

HYDRONCO 500 Capsules
Composition: Hydroxyurea Capsules IP 500mg

HYDRONCO 500 is a high-quality Hydroxyurea 500mg Capsule IP, a well-established antineoplastic and disease-modifying agent. Manufactured in WHO-GMP certified facilities, HYDRONCO Capsules are supplied by trusted pharmaceutical exporters from India to support global oncology and hematology treatment programs, particularly in the management of myeloproliferative disorders and sickle cell disease.

Hydroxyurea works by inhibiting ribonucleotide reductase, thereby interfering with DNA synthesis and reducing the proliferation of rapidly dividing cells. HYDRONCO 500 Capsules are primarily indicated for the treatment of chronic myeloid leukemia (CML), polycythemia vera, essential thrombocythemia, and for reducing the frequency of painful crises in patients with sickle cell anemia.

HYDRONCO 500 Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, oncology and hematology centers, government health programs, and international pharmaceutical distributors.

IMEC-A+ Tablets
Composition: Ivermectin & Albendazole
Dosage Form: Oral Tablet

IMEC-A+ is a high-quality combination tablet containing Ivermectin and Albendazole, two widely recognized antiparasitic agents with broad-spectrum activity. Manufactured in WHO-GMP certified facilities, IMEC-A+ Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global programs for the treatment and control of parasitic infections.

Ivermectin works by binding to specific channels in the nerve and muscle cells of parasites, leading to paralysis and death of the organisms, while Albendazole inhibits microtubule formation in parasitic cells, disrupting their metabolism and growth. IMEC-A+ Tablets are primarily indicated for the treatment of a wide range of intestinal worms, filariasis, and other parasitic infections, as prescribed by a healthcare professional.

IMEC-A+ Ivermectin & Albendazole Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, government health programs, and international pharmaceutical distributors.

Acabrunat 100mg Capsules
Composition: Acalabrutinib 100mg
International Trade Name: Calquence®

Acabrunat 100mg is a high-quality Acalabrutinib 100mg Capsule, a selective Bruton’s tyrosine kinase (BTK) inhibitor marketed under the brand name Calquence®. Manufactured in WHO-GMP certified facilities, Acabrunat Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in B-cell malignancies.

Acalabrutinib works by selectively inhibiting BTK, a key enzyme in the B-cell receptor signaling pathway, thereby preventing the growth and survival of malignant B-cells. Acabrunat 100mg Capsules are primarily indicated for the treatment of adult patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL), including patients who have received prior therapies.

Acabrunat 100mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for oncology centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Renocrit 10,000 IU Injection
Composition: Erythropoietin Injection 10,000 IU
International Trade Name: Epogen® / Eprex®
Renocrit 10,000 IU is a high-quality Erythropoietin Injection, a recombinant human erythropoietin widely recognized for stimulating red blood cell production. Manufactured in WHO-GMP certified facilities, Renocrit Injection is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in the management of anemia associated with chronic kidney disease, chemotherapy, or other medical conditions.
Erythropoietin works by stimulating erythroid progenitor cells in the bone marrow, leading to increased production of red blood cells and improved oxygen-carrying capacity. Renocrit 10,000 IU Injection is primarily indicated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia induced by chemotherapy, and other clinical situations requiring erythropoiesis-stimulating therapy under medical supervision.
Renocrit 10,000 IU Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, dialysis centers, tertiary care facilities, and international pharmaceutical distributors.

 

Mofecon 500 Tablets
Composition: Mycophenolate Mofetil IP 500mg
Dosage Form: Oral Tablet

Mofecon 500 is a high-quality Mycophenolate Mofetil 500mg tablet, a potent immunosuppressant widely recognized for its efficacy in preventing organ transplant rejection. Manufactured in WHO-GMP certified facilities, Mofecon 500 is supplied by trusted pharmaceutical exporters from India to support advanced global transplant care programs.

Mycophenolate Mofetil works by inhibiting the proliferation of T- and B-lymphocytes, thereby reducing the risk of graft rejection following kidney, heart, or liver transplantation. Mofecon 500mg Tablets are primarily indicated for the prevention of organ transplant rejection in combination with other immunosuppressive agents, and in the treatment of certain autoimmune disorders as prescribed by a healthcare professional.

 

Mofecon 500 Mycophenolate Mofetil Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

Rituxirel 100mg Injection
Composition: Rituximab 100mg
Dosage Form: Injectable

Rituxirel 100mg is a high-quality Rituximab injection, a monoclonal antibody widely recognized for its efficacy in the treatment of hematological malignancies and certain autoimmune disorders. Manufactured in WHO-GMP certified facilities, Rituxirel Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology and immunology treatment programs.

Rituximab specifically targets the CD20 antigen present on B-lymphocytes, leading to their depletion and modulation of abnormal immune responses. Rituxirel 100mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and various autoimmune conditions such as rheumatoid arthritis, under the guidance of a healthcare professional.

Rituxirel Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, oncology centers, specialty clinics, government healthcare programs, and international pharmaceutical distributors.

Cidmus 50mg Tablets
Composition: Sacubitril 24mg & Valsartan 26mg (equivalent to Sacubitril and Valsartan 50mg)
Dosage Form: Oral Tablet

Cidmus 50mg is a high-quality combination tablet containing Sacubitril and Valsartan, a novel angiotensin receptor-neprilysin inhibitor (ARNI) widely recognized for its efficacy in managing chronic heart failure. Manufactured in WHO-GMP certified facilities, Cidmus 50mg is supplied by trusted pharmaceutical exporters from India to support advanced global cardiovascular care programs.

Sacubitril inhibits neprilysin, enhancing beneficial natriuretic peptides, while Valsartan blocks the angiotensin II receptor, reducing vasoconstriction and aldosterone-mediated sodium retention. Together, this dual action improves cardiac function, reduces hospitalizations, and enhances survival in patients with heart failure with reduced ejection fraction (HFrEF). Cidmus 50mg Tablets are primarily indicated for the treatment of symptomatic chronic heart failure in adult patients, as prescribed by a healthcare professional.

Cidmus Sacubitril and Valsartan 50mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, cardiology clinics, government healthcare programs, and international pharmaceutical distributors.

Maballa 100 Injection
Composition: Rituximab 100mg/10ml
Dosage Form: Injectable

Maballa 100 is a high-quality Rituximab injection, a monoclonal antibody widely recognized for its efficacy in the treatment of hematological malignancies and certain autoimmune disorders. Manufactured in WHO-GMP certified facilities, Maballa 100 Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology and immunology treatment programs.

Rituximab targets the CD20 antigen on B-lymphocytes, leading to their depletion and modulation of abnormal immune responses. Maballa 100 Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and autoimmune conditions such as rheumatoid arthritis, under the supervision of a healthcare professional.

Maballa 100 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, oncology centers, specialty clinics, government healthcare programs, and international pharmaceutical distributors.

Ferinject 500 Injection/Infusion
Composition: Ferric Carboxymaltose Solution 500mg/10ml
International Trade Name: Injectafer®

Ferinject 500 is a high-quality Ferric Carboxymaltose Solution for Injection/Infusion, a widely recognized intravenous iron preparation marketed under the brand name Injectafer®. Manufactured in WHO-GMP certified facilities, Ferinject is supplied by trusted pharmaceutical exporters from India to support advanced global healthcare programs, particularly in the management of iron deficiency anemia.

Ferric Carboxymaltose is a stable iron complex designed for rapid and controlled delivery of iron to the body, enabling efficient replenishment of iron stores with minimal risk of free iron toxicity. Ferinject 500 is primarily indicated for the treatment of iron deficiency anemia in patients who cannot tolerate or do not respond adequately to oral iron therapy, including those with chronic kidney disease, inflammatory bowel disease, postpartum anemia, and other conditions associated with iron deficiency.

Ferinject 500 Injection/Infusion is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The solution is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, infusion centers, government health programs, and international pharmaceutical distributors.

Corovir 100mg Injection
Composition: Remdesivir for Injection 100mg
International Trade Name: Veklury®

Corovir 100mg is a high-quality Remdesivir for Injection, a broad-spectrum antiviral agent marketed under the brand name Veklury®. Manufactured in WHO-GMP certified facilities, Corovir Injection is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in the management of viral infections requiring advanced hospital-based care.

Remdesivir is a nucleotide analog prodrug that inhibits viral RNA-dependent RNA polymerase, thereby preventing viral replication within host cells. Corovir 100mg Injection is primarily indicated for the treatment of hospitalized patients with severe viral infections, including COVID-19, where it helps reduce viral load and improve clinical recovery under medical supervision.

Corovir 100mg Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The lyophilized powder is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units, government health programs, and international pharmaceutical distributors.

Emgrast 300mcg Injection
Composition: Filgrastim Injection 300mcg
International Trade Name: Neupogen®

Emgrast 300mcg is a high-quality Filgrastim 300mcg Injection, a biosimilar equivalent of the internationally recognized granulocyte colony-stimulating factor (G-CSF) marketed under the brand name Neupogen®. Manufactured in WHO-GMP certified facilities, Emgrast Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology and hematology treatment programs, particularly in chemotherapy-induced neutropenia and bone marrow recovery.

Filgrastim is a recombinant human G-CSF that stimulates the production, maturation, and activation of neutrophils, helping reduce the duration and severity of neutropenia. Emgrast 300mcg Injection is primarily indicated for the prevention of chemotherapy-induced neutropenia, mobilization of hematopoietic progenitor cells for transplantation, and treatment of severe chronic neutropenia.

Emgrast 300mcg Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology and hematology infusion centers, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Cidonat Injection
Composition: Cidofovir Injection USP 75 mg/ml (375mg/5ml)
Dosage Form: Injectable

Cidonat is a high-quality Cidofovir injection, a potent antiviral agent widely recognized for its efficacy against serious viral infections, particularly those caused by cytomegalovirus (CMV). Manufactured in WHO-GMP certified facilities, Cidonat Injection is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral therapy programs.

Cidofovir works by inhibiting viral DNA polymerase, thereby preventing viral replication and helping to control viral infections in immunocompromised patients. Cidonat Injection is primarily indicated for the treatment of CMV retinitis in patients with AIDS and for other severe viral infections as determined by a healthcare professional.

 

Cidonat Cidofovir Injection USP is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, specialized clinics, government health programs, and international pharmaceutical distributors

Corovir Lyophilized Powder for Injection
Composition: Remdesivir Lyophilized Powder for Injection
International Trade Name: Veklury®

Corovir Lyophilized Powder is a high-quality Remdesivir preparation for injection, a broad-spectrum antiviral agent marketed under the brand name Veklury®. Manufactured in WHO-GMP certified facilities, Corovir Lyophilized Powder is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in the management of severe viral infections requiring hospital-based care.

Remdesivir is a nucleotide analog prodrug that inhibits viral RNA-dependent RNA polymerase, preventing viral replication within host cells. Corovir Lyophilized Powder is primarily indicated for the treatment of hospitalized patients with viral infections, including COVID-19, to help reduce viral load and improve clinical recovery under medical supervision.

Corovir Lyophilized Powder for Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The lyophilized powder is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units, government health programs, and international pharmaceutical distributors.

Vegaforce-100
Composition: Sildenafil Citrate 100mg
International Trade Name: Viagra®

Vegaforce-100 is a high-quality Sildenafil Citrate 100mg tablet, a widely recognized phosphodiesterase type 5 (PDE5) inhibitor marketed under the brand name Viagra®. Manufactured in WHO-GMP certified facilities, Vegaforce-100 is supplied by trusted pharmaceutical exporters from India to support global men’s health programs, particularly in the management of erectile dysfunction (ED).

Sildenafil Citrate works by selectively inhibiting PDE5, leading to increased blood flow to the penis during sexual stimulation, thereby facilitating the achievement and maintenance of an erection. Vegaforce-100 is primarily indicated for the treatment of erectile dysfunction in adult men and may also be used under medical supervision for other conditions related to impaired vascular function.

Vegaforce-100 Sildenafil 100mg tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pharmacies, hospitals, clinics, and international pharmaceutical distributors.

Linzolieva 600mg Tablets
Composition: Linezolid 600mg
International Trade Name: Zyvox®

Linzolieva 600mg is a high-quality Linezolid 600mg tablet, a globally recognized antibiotic for the treatment of serious Gram-positive bacterial infections. Manufactured in WHO-GMP certified facilities, Linzolieva is supplied by trusted pharmaceutical exporters from India to support advanced global healthcare programs, particularly in managing multidrug-resistant bacterial infections.

Linezolid is an oxazolidinone-class antibiotic that works by inhibiting bacterial protein synthesis, offering potent activity against resistant strains such as MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococci). Linzolieva 600mg is primarily indicated for the treatment of severe infections where conventional antibiotics may be ineffective.

Linzolieva 600mg tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, tertiary care centers, government health programs, and international pharmaceutical distributors.

Lomocare Injection
Composition: Enoxaparin Sodium
Dosage Form: Injectable

Lomocare is a high-quality Enoxaparin injection, a low molecular weight heparin (LMWH) widely recognized for its anticoagulant efficacy in the prevention and treatment of thromboembolic disorders. Manufactured in WHO-GMP certified facilities, Lomocare Injection is supplied by trusted pharmaceutical exporters from India to support advanced global cardiovascular and critical care programs.

Enoxaparin works by selectively inhibiting factor Xa and to a lesser extent factor IIa (thrombin), preventing the formation and extension of blood clots. Lomocare Injection is primarily indicated for the prophylaxis and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary syndromes (ACS), and other conditions requiring anticoagulation, under the supervision of a healthcare professional.

Lomocare Enoxaparin Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, specialty clinics, government healthcare programs, and international pharmaceutical distributors.

Enfiera 500mg Injection
Composition: Rituximab 500mg Injection
International Trade Name: Rituxan® / MabThera®

Enfiera 500mg is a high-quality Rituximab 500mg Injection, a well-established monoclonal antibody targeted therapy marketed under the brand names Rituxan® and MabThera®. Manufactured in WHO-GMP certified facilities, Enfiera Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology and immunology treatment programs, particularly in B-cell malignancies and certain autoimmune disorders.

Rituximab works by selectively binding to the CD20 antigen on the surface of B-lymphocytes, leading to B-cell depletion through antibody-dependent cellular cytotoxicity, complement-mediated cytotoxicity, and induction of apoptosis. Enfiera 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and other B-cell mediated conditions under specialist supervision.

Enfiera 500mg Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology and immunology infusion centers, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Mito 40mg Injection
Composition: Mitomycin 40mg
Dosage Form: Injectable

Mito 40mg is a high-quality Mitomycin 40mg injection, a well-established antineoplastic antibiotic widely recognized for its efficacy in the treatment of various solid tumors. Manufactured in WHO-GMP certified facilities, Mito Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Mitomycin works by inhibiting DNA synthesis and cross-linking DNA strands, thereby preventing the replication of cancer cells and inducing cell death. Mito 40mg Injection is primarily indicated for the treatment of cancers such as gastric cancer, pancreatic cancer, breast cancer, and bladder cancer, either as monotherapy or in combination with other chemotherapeutic agents, as per clinical protocols.

Mito 40mg Mitomycin Injection is manufactured under stringent GMP and oncology-grade quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

LYCOVORA 50 Injection
Composition: Leucovorin Calcium Injection IP (Folinic Acid) 50mg
Dosage Form: Injectable

LYCOVORA 50 is a high-quality Leucovorin Calcium injection, a biologically active form of folic acid widely recognized for its role in reducing the toxic effects of certain anticancer therapies and enhancing the efficacy of specific chemotherapy agents. Manufactured in WHO-GMP certified facilities, LYCOVORA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Leucovorin Calcium works by replenishing reduced folate levels in the body, helping to protect healthy cells from the harmful effects of folate antagonists such as methotrexate. It is also used to enhance the therapeutic action of fluoropyrimidines like 5-fluorouracil (5-FU). LYCOVORA 50 Injection is primarily indicated for methotrexate rescue therapy, the treatment of folate deficiency, and as an adjunct in combination chemotherapy regimens, as per established clinical protocols.

LYCOVORA 50 Leucovorin Calcium Injection is manufactured under stringent GMP and oncology-grade quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

BLEOMYRA 15 Units Injection
Composition: Bleomycin Injection IP 15 Units
International Trade Name: Blenoxane®

BLEOMYRA 15 Units is a high-quality Bleomycin Injection IP, a well-established antineoplastic antibiotic marketed under the brand name Blenoxane®. Manufactured in WHO-GMP certified facilities, BLEOMYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in the management of various solid tumors and lymphomas.

Bleomycin works by inducing DNA strand breaks through free radical formation, thereby inhibiting DNA synthesis and leading to apoptosis in rapidly dividing cancer cells. BLEOMYRA 15 Units Injection is primarily indicated for the treatment of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, squamous cell carcinomas of the head and neck, cervix, and skin, often as part of combination chemotherapy regimens.

BLEOMYRA 15 Units Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

IRNOTYRA 100mg/5ml Injection
Composition: Irinotecan Hydrochloride Injection IP 100mg/5ml
International Trade Name: Camptosar®

IRNOTYRA 100mg/5ml is a high-quality Irinotecan Hydrochloride Injection IP, a well-established topoisomerase I inhibitor marketed under the brand name Camptosar®. Manufactured in WHO-GMP certified facilities, IRNOTYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in the management of gastrointestinal and solid tumors.

Irinotecan works by inhibiting the enzyme topoisomerase I, thereby interfering with DNA replication and transcription in rapidly dividing cancer cells, ultimately leading to cell death. IRNOTYRA 100mg/5ml Injection is primarily indicated for the treatment of colorectal cancer, either as monotherapy or in combination with other chemotherapeutic agents, and is also used in the management of other advanced solid malignancies under specialist supervision.

IRNOTYRA 100mg/5ml Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

DOCEMYRA-RTU 20mg/1ml Injection
Composition: Docetaxel Injection IP 20mg/1ml
International Trade Name: Taxotere®

DOCEMYRA-RTU 20mg/1ml is a high-quality Docetaxel Injection IP, a well-established taxane-class chemotherapeutic agent marketed under the brand name Taxotere®. Manufactured in WHO-GMP certified facilities, DOCEMYRA-RTU is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in the management of various solid tumors.

Docetaxel works by promoting and stabilizing microtubule assembly while inhibiting their disassembly, thereby disrupting cell division and leading to apoptosis in rapidly dividing cancer cells. DOCEMYRA-RTU 20mg/1ml Injection is primarily indicated for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers, either as monotherapy or in combination with other anticancer agents.

DOCEMYRA-RTU 20mg/1ml Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The ready-to-use formulation is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

L ASPYRA 5000 IU Injection
Composition: L-Asparaginase 5000 IU for Injection
International Trade Name: Elspar®

L ASPYRA 5000 IU is a high-quality L-Asparaginase Injection, a well-established antineoplastic enzyme preparation marketed under the brand name Elspar®. Manufactured in WHO-GMP certified facilities, L ASPYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in the management of acute lymphoblastic leukemia (ALL).

L-Asparaginase works by depleting the amino acid asparagine, which is essential for the survival of certain malignant lymphoblasts. By reducing circulating asparagine levels, L ASPYRA 5000 IU Injection inhibits protein synthesis in cancer cells, leading to growth arrest and cell death. It is primarily indicated for the treatment of acute lymphoblastic leukemia (ALL) and is commonly used as part of combination chemotherapy regimens.

L ASPYRA 5000 IU Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The lyophilized powder is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

DESIROX 500 Tablets
Composition: Deferasirox 500mg
Dosage Form: Dispersible Tablet

DESIROX 500 is a high-quality Deferasirox dispersible tablet, a potent oral iron chelator widely recognized for its efficacy in the treatment of chronic iron overload. Manufactured in WHO-GMP certified facilities, DESIROX 500 Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and transfusion care programs.

Deferasirox works by binding excess iron in the body and facilitating its excretion, thereby preventing the harmful effects of iron accumulation in organs such as the liver, heart, and endocrine glands. DESIROX 500 Dispersible Tablets are primarily indicated for the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia, sickle cell disease, and other chronic anemias, under the supervision of a healthcare professional.

DESIROX 500 Deferasirox Dispersible Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government health programs, and international pharmaceutical distributors.

PARABOOST IV Infusion 100ml
Composition: Paracetamol Infusion IP 100ml

PARABOOST IV Infusion 100ml is a high-quality Paracetamol intravenous infusion, a well-established analgesic and antipyretic widely used for the management of pain and fever. Manufactured in WHO-GMP certified facilities, PARABOOST IV Infusion is supplied by trusted pharmaceutical exporters from India to support global healthcare programs, particularly in hospitals and critical care settings.

Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system and modulating the hypothalamic heat-regulating center, thereby providing effective relief from pain and fever. PARABOOST IV Infusion is primarily indicated for the management of moderate pain, postoperative pain, musculoskeletal pain, and fever, and can be used as part of multimodal analgesic therapy under medical supervision.

PARABOOST IV Infusion 100ml is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, surgical centers, intensive care units, and international pharmaceutical distributors.

ENCICARB 500 Injection
Composition: Ferric Carboxymaltose 500mg/10ml
Dosage Form: Injectable

ENCICARB 500 is a high-quality Ferric Carboxymaltose injection, a modern intravenous iron formulation widely recognized for its effectiveness in the rapid correction of iron deficiency and iron deficiency anemia. Manufactured in WHO-GMP certified facilities, ENCICARB Injection is supplied by trusted pharmaceutical exporters from India to support advanced global hematology and general healthcare treatment programs.

Ferric Carboxymaltose is a stable iron complex that allows controlled release of iron, enabling efficient replenishment of iron stores with minimal risk of free iron toxicity. ENCICARB 500 Injection is primarily indicated for the treatment of iron deficiency anemia in patients who are intolerant to or unresponsive to oral iron therapy, including those with chronic kidney disease, inflammatory bowel disease, postpartum anemia, and other conditions associated with iron deficiency.

ENCICARB 500 Ferric Carboxymaltose Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, infusion centers, dialysis units, government health programs, and international pharmaceutical distributors.

Coly-Monas 2 Powder
Composition: Colistimethate Sodium 2 MIU
Dosage Form: Powder for Solution for Injection, Infusion, or Inhalation

Coly-Monas 2 is a high-quality Colistimethate Sodium powder, a potent polymyxin-class antibiotic widely recognized for its efficacy against multidrug-resistant Gram-negative bacterial infections. Manufactured in WHO-GMP certified facilities, Coly-Monas 2 is supplied by trusted pharmaceutical exporters from India to support advanced global antimicrobial therapy programs.

Colistimethate Sodium works by disrupting the bacterial cell membrane, leading to cell death and rapid clearance of susceptible pathogens. Coly-Monas 2 Powder is primarily indicated for the treatment of severe infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Acinetobacter spp., and Klebsiella spp., and can be administered via intravenous injection, infusion, or inhalation, as prescribed by a healthcare professional.

 

Coly-Monas 2 Colistimethate Sodium Powder is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The powder is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, intensive care units, government health programs, and international pharmaceutical distributors.

Bonista PF Injection
Composition: Teriparatide 600mcg/2.4ml
Dosage Form: Injectable

Bonista PF is a high-quality Teriparatide injection, a recombinant human parathyroid hormone widely recognized for its efficacy in the treatment of osteoporosis. Manufactured in WHO-GMP certified facilities, Bonista PF Injection is supplied by trusted pharmaceutical exporters from India to support advanced global bone health and osteoporosis management programs.

Teriparatide works by stimulating new bone formation through activation of osteoblasts, thereby increasing bone mineral density and reducing the risk of fractures in patients with severe osteoporosis. Bonista PF Injection is primarily indicated for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture, as well as in patients with glucocorticoid-induced osteoporosis, under the supervision of a healthcare professional.

Bonista PF Teriparatide Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, endocrinology clinics, government health programs, and international pharmaceutical distributors.